Composition
- Active ingredients
- ISAVUCONAZONIUM SULFATE 372MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ISAVUCONAZONIUM SULFATE 372MG · PowderThis page
- ISAVUCONAZONIUM SULFATE 74.5MG · CapsuleNDA207500-002 · Prescription
- ISAVUCONAZONIUM SULFATE 186MG · CapsuleNDA207500-001 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA207501.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Cresemba
- Active substance
- isavuconazonium sulfate
- Route
- Intravenous
- Dosage form
- Powder
- Applicant
- Astellas
- Status
- Prescription
- FDA approval
- 6 Mar 2015
- Application
- NDA207501-001